Furthermore, Ovsyannikova et al. reported a case of an individual with ABCC8-MODY in whom combining sodium-glucose co-transporter 2 inhibitors (SGLT2i) with a sulfonylurea resulted in improved glycemic variability parameters without hypoglycemia [5]. Here, ABCC8 is linked to Hypoglycemia.